Michael Erman
Michael Erman
I write for Reuters. My articles can be found here: http://blogs.reuters.com/michael-erman/Source
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
2 reviews

RECENT ARTICLES

Sort by:
No Rating
Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed

Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed

By , Remdesivir has been at the forefront of the global battle against COVID-19 after the intravenously administered medicine helped shorten hospital recovery times, according to data in April from a separate U.S. government trial. That study showed a trend toward better survival for remdesivir but the difference was not statistically significant.In the latest analysis, Gilead said it analyzed data from 312 patients treated in its late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity.Gilead’s late-stage study...

July 10, 2020
Share
Save
Review
No Rating
Novartis to test efficacy of old malaria drug against COVID-19

Novartis to test efficacy of old malaria drug against COVID-19

By , ZURICH/NEW YORK (Reuters) - Swiss drugmaker Novartis AG said on Monday it will test the malaria drug hydroxychloroquine in a randomized trial to see if the much talked about medicine is actually effective against COVID-19, the illness caused by the novel coronavirus.The company hopes to have data on its efficacy by June, a lead researcher for the trial told Reuters.The decades-old generic medicine has been touted by U.S. President Donald Trump and others as a “game changer” treatment for the highly contagious respiratory illness, and the U.S. Food and Drug Administration authorized it...

April 20, 2020
Share
Save
Review
No Rating
Pfizer, BioNTech set to begin U.S. coronavirus vaccine trial

Pfizer, BioNTech set to begin U.S. coronavirus vaccine trial

By , The U.S. drugmaker and German partner said if the vaccine proves to be safe and effective in trials, it could potentially be ready for wide U.S. distribution by the end of the year, shaving several years off the typical vaccine development timeline.The vaccine, which uses messenger RNA (mRNA) technology, has the potential to be among the first vaccines against the virus that has infected more than 1 million people in the United States and killed some 68,000.There are currently no approved treatments or vaccines for the new coronavirus, though some drugs are being used on patients under...

+1
May 5, 2020
Share
Save
Review
No Rating
Government officials respond to Reuters report on secrecy of coronavirus discussions

Government officials respond to Reuters report on secrecy of coronavirus discussions

By , , WASHINGTON (Reuters) - The head of the U.S. Centers for Disease Control and Prevention testified on Thursday on Capitol Hill that public health officials discussed coronavirus information in classified rooms on occasions “too numerous to count,” though he said the information wasn’t treated as classified.On Wednesday, Reuters reported that the White House ordered federal health officials at the Department of Health and Human Services (HHS), the nation’s premier health agency, to treat top-level coronavirus meetings as classified, citing four Trump administration officials.The...

+1
March 13, 2020
Share
Save
Review
No Rating
U.S. parents begin to ask: Should my child get a COVID-19 shot?

U.S. parents begin to ask: Should my child get a COVID-19 shot?

The Sweeten children, Kaden, Jackson and Emily, are seen at their home in Layton, Utah, U.S., November 8, 2020. Picture taken November 8, 2020. Tristen Sweeten/Handout via REUTERS Register now for FREE unlimited access to Reuters.comApril 16 (Reuters) - Tristen Sweeten, a 34-year-old nurse in Utah, hopes her three children will receive Moderna's COVID-19 vaccine through its pediatric clinical trial. The sooner the better, she said, for their safety and the greater goal of ending the pandemic.Angie Ankoma, a 45-year-old Black mother of four who works in philanthropy in Rhode Island, believes...

April 16, 2021
Share
Save
Review
No Rating
U.S. near authorization of Johnson & Johnson COVID-19 vaccine

U.S. near authorization of Johnson & Johnson COVID-19 vaccine

By , (Reuters) - U.S. regulators on Friday said they would work quickly to authorize Johnson & Johnson’s COVID-19 vaccine for emergency use after a panel of outside advisers backed the one-shot immunization.The Food and Drug Administration is expected to decide on emergency use by Saturday for what would be the third vaccine available in the United States, and the only one that requires a single shot.The agency told J&J that “it will rapidly work toward finalization and issuance of an emergency use authorization,” the regulator said in a statement after the vote by advisers.“The...

February 26, 2021
Share
Save
Review
No Rating
Pfizer says South African variant could significantly reduce protective antibodies

Pfizer says South African variant could significantly reduce protective antibodies

By (This February 17 story corrects headline and first paragraph to show the reduction was in the protective antibodies elicited by the vaccine, not the protection of the vaccine overall)Slideshow (Reuters) - A laboratory study suggests that the South African variant of the coronavirus may reduce protective antibodies elicited by the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.The study found the vaccine was still able to neutralize the virus and there is not yet evidence from trials in...

February 17, 2021
Share
Save
Review
No Rating
Pfizer says South African variant could significantly reduce protective antibodies

Pfizer says South African variant could significantly reduce protective antibodies

By (This February 17 story corrects headline and first paragraph to show the reduction was in the protective antibodies elicited by the vaccine, not the protection of the vaccine overall)Slideshow (Reuters) - A laboratory study suggests that the South African variant of the coronavirus may reduce protective antibodies elicited by the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.The study found the vaccine was still able to neutralize the virus and there is not yet evidence from trials in...

February 17, 2021
Share
Save
Review
No Rating
Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk

Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk

By , NEW YORK (Reuters) - Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.The hikes come as drugmakers are reeling from effects of the COVID-19 pandemic, which has reduced doctor visits and demand for some drugs. They are also fighting new drug price cutting rules from the Trump administration, which would reduce the industry’s profitability.The companies kept their price increases at 10% or below, and the...

+1
December 31, 2020
Share
Save
Review
No Rating
U.S. investigating 5 allergic reactions to Pfizer coronavirus vaccine - National | Globalnews.ca

U.S. investigating 5 allergic reactions to Pfizer coronavirus vaccine - National | Globalnews.ca

Want to discuss? Please read our first.AdvertisementClose XAAThe U.S. Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE’s vaccine in the United States this week, a top FDA official said late on Friday.Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said at a press conference that the allergic reactions had been reported in more than one state, including in Alaska.Marks also said that a chemical called polyethylene glycol (PEG) that is an ingredient in the...

December 19, 2020
Share
Save
Review
  • Total 15 items
  • 1
  • 2
OUTLETS
yahoo.com

yahoo.com

CRITIC
img-trusted
94%
PUBLIC
img-trusted
85%
reuters.com

reuters.com

CRITIC
img-trusted
100%
PUBLIC
img-trusted
78%
globalnews.ca

globalnews.ca

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A